Traws Pharma (STU:0T20) Interest Expense : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Traws Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Traws Pharma's interest expense for the three months ended in Sep. 2024 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Traws Pharma's Operating Income for the three months ended in Sep. 2024 was € -7.69 Mil. Traws Pharma's Interest Expense for the three months ended in Sep. 2024 was € 0.00 Mil. Traws Pharma has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Traws Pharma Interest Expense Historical Data

The historical data trend for Traws Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Traws Pharma Interest Expense Chart

Traws Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

Traws Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Traws Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Traws Pharma (STU:0T20) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Traws Pharma's Interest Expense for the three months ended in Sep. 2024 was €0.00 Mil. Its Operating Income for the three months ended in Sep. 2024 was €-7.69 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €0.00 Mil.

Traws Pharma's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Traws Pharma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Traws Pharma Inc has no debt.

Traws Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Traws Pharma Inc (STU:0T20) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

TRAW:USA

Address

12 Penns Trail, Newtown, PA, USA, 18940

Website

https://www.onconova.com

Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.

Traws Pharma Headlines

No Headlines